BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7332605)

  • 1. The lipid-lowering profile in rodents. AZ-1355, a new dibenzoxazepine derivative.
    Wada S; Koizumi M; Sasahara K; Neichi T; Nakakimura H; Onoda F; Hata SI
    Atherosclerosis; 1981; 40(3-4):263-71. PubMed ID: 7332605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
    Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH
    Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.
    O'Brien M; Patel ST; Mukhopadhyay A; Newman HA; Feller DR; Kokrady SS; Witiak DT; Lanese RR; Rice JC
    Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the lipid-lowering activity of AY-25,712 in rats.
    Cayen MN; Kallai-Sanfacon MA; Dubuc J; Greselin E; Dvornik D
    Atherosclerosis; 1982 Dec; 45(3):267-79. PubMed ID: 6818976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering actions of 7-(2-methylene butyryl)-(2H)-1,4-benzoxazin-3-(4H)-one derivatives in mice, rats and Syrian hamsters.
    Moussavi Z; Plancke MO; Olivier P; Lesieur D; Fruchart JC; Sauzieres J
    Clin Chim Acta; 1989 Mar; 180(1):35-44. PubMed ID: 2743567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering effect of cordycepin (3'-deoxyadenosine) from Cordyceps militaris on hyperlipidemic hamsters and rats.
    Gao J; Lian ZQ; Zhu P; Zhu HB
    Yao Xue Xue Bao; 2011 Jun; 46(6):669-76. PubMed ID: 21882527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats and hamsters. I. Comparative action of clofibrate and tiadenol on hepatic and intestinal biosynthesis of cholesterol in hamsters and rats].
    Rousselet F; Fredj G; Clenet M
    Ann Pharm Fr; 1986; 44(4):269-76. PubMed ID: 3566092
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
    Huang Y; Hall IH
    Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteins.
    Sirtori CR; Gomarasca P; D'Atri G; Cerutti S; Tronconi G; Scolastico C
    Atherosclerosis; 1978 May; 30(1):45-56. PubMed ID: 209796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents.
    Hall IH; Griffin TS; Docks EL; Brotherton RJ; Futch G
    J Pharm Sci; 1986 Jul; 75(7):706-10. PubMed ID: 3761173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering effects of N-[4-methylbenzylthiocarbonyl]-L-phenylalanine (KF1492), a new phenylalanine derivative.
    Yamada K; Shuto K; Kojima T; Marumo H; Tanaka M
    J Pharmacobiodyn; 1982 Aug; 5(8):611-8. PubMed ID: 7153833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidemic activity of the surfactants aminimides, and their effects on lipid metabolism of rodents.
    Hall IH; Kabara JJ; Matthews TG
    Lipids; 1985 Oct; 20(10):685-92. PubMed ID: 2865666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and hypolipidaemic evaluation of a series of alpha-asarone analogues related to clofibrate in mice.
    Labarrios F; Garduño L; Vidal MR; Garcia R; Salazar M; Martinez E; Diaz F; Chamorro G; Tamariz J
    J Pharm Pharmacol; 1999 Jan; 51(1):1-7. PubMed ID: 10197410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents.
    Huang Y; Hall IH
    Arch Pharm (Weinheim); 1996 Jul; 329(7):329-38. PubMed ID: 8764881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic effect of ethyl all-cis-5,8,11,14,17-eicosapentaenoate (EPA-E) in rats.
    Mizuguchi K; Yano T; Kojima M; Tanaka Y; Ishibashi M; Masada A; Sato M; Mizota M; Fukutake K; Saito Y
    Jpn J Pharmacol; 1992 Jul; 59(3):307-12. PubMed ID: 1434127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypolipidemic activity of 1-N-3-methylphthalimido-butan-3-semicarbazone in rodents.
    Wong OT; Hall IH; Chapman JM
    Pharm Res; 1989 Mar; 6(3):230-4. PubMed ID: 2726679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and hypolipidemic activity of 3-imino-1-oxoisoindolines in rodents.
    Murthy AR; Wong OT; Reynolds DJ; Hall IH
    Pharm Res; 1987 Feb; 4(1):21-7. PubMed ID: 3508524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypolipidemic activity of 3-amino-1-(2,3,4-mononitro-, mono-, or dihalophenyl)propan-1-ones in rodents.
    Huang Y; Hall IH
    Arch Pharm (Weinheim); 1996 Jul; 329(7):339-46. PubMed ID: 8764882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The hypolipidemic and liver protective effect of (Z)-N-(2-hydroxyethyl) docos-13-enamide on hyperlipidemic golden hamsters].
    Shen YH; Jin X; Zhao Y; Altunbak G; Lin LM; Shu P; Wei X
    Yao Xue Xue Bao; 2012 Sep; 47(9):1252-6. PubMed ID: 23227559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
    Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.